ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC16736-10mM (in 1mL DMSO) |
|
124083-20-1 |
Etomoxir
|
0 | C17H23ClO4 | |
GC16736-50mg |
|
124083-20-1 |
Etomoxir
|
0 | C17H23ClO4 | |
GC16736-10mg |
|
124083-20-1 |
Etomoxir
|
0 | C17H23ClO4 | |
GC16735-50mg |
|
96795-89-0 |
(±)-McN 5652
|
0 | C19H21NS | |
GC16735-10mg |
|
96795-89-0 |
(±)-McN 5652
|
0 | C19H21NS | |
GC16734-10mM (in 1mL DMSO) |
|
929016-96-6 |
Pracinostat (SB939)
|
0 | C20H30N4O2 | |
GC16734-50mg |
|
929016-96-6 |
Pracinostat (SB939)
|
0 | C20H30N4O2 | |
GC16734-10mg |
|
929016-96-6 |
Pracinostat (SB939)
|
0 | C20H30N4O2 | |
GC16734-5mg |
|
929016-96-6 |
Pracinostat (SB939)
|
0 | C20H30N4O2 | |
GC16733-10mM (in 1mL DMSO) |
|
274901-16-5 |
Vildagliptin (LAF-237)
|
0 | C17H25N3O2 | |
GC16733-100mg |
|
274901-16-5 |
Vildagliptin (LAF-237)
|
0 | C17H25N3O2 | |
GC16733-50mg |
|
274901-16-5 |
Vildagliptin (LAF-237)
|
0 | C17H25N3O2 | |
GC16733-10mg |
|
274901-16-5 |
Vildagliptin (LAF-237)
|
0 | C17H25N3O2 | |
GC16732-10mM (in 1mL DMSO) |
|
252916-29-3 |
TSU-68 (SU6668,Orantinib)
|
0 | C18H18N2O3 | |
GC16732-50mg |
|
252916-29-3 |
TSU-68 (SU6668,Orantinib)
|
0 | C18H18N2O3 | |
GC16732-10mg |
|
252916-29-3 |
TSU-68 (SU6668,Orantinib)
|
0 | C18H18N2O3 | |
GC16732-5mg |
|
252916-29-3 |
TSU-68 (SU6668,Orantinib)
|
0 | C18H18N2O3 | |
GC16731-50mg |
|
1191911-27-9 |
CZC 54252 hydrochloride
|
0 | C22H25ClN6O4S.HCl | |
GC16731-10mg |
|
1191911-27-9 |
CZC 54252 hydrochloride
|
0 | C22H25ClN6O4S.HCl | |
GC16728-50mg |
|
733734-61-7 |
SB 706375
|
0 | C20H22BrF3N2O5S | |